Royal Philips (NYSE:PHG) announced recently that it has launched the clinical trial accelerator on its Philips HealthSuite to improve trial efficiency.
The Amsterdam-based company’s accelerator includes a new, tailored set of capabilities to enable life science organizations to integrate, analyze and store clinical and patient-reported data from multiple sources, according to a news release.
Philips HealthSuite uses HIPAA-compliant, secure cloud capabilities to allow for patient-centric trials to take place at home and manage data collection while offering security and compliance as attempts to increase efficiency in trial design.